ARCHIVES

Early ADT Doesn’t Offer Survival Advantage—ASCO

This article is from The Cancer Letter archive.

Vol. 30 No. 4 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

Phase III Lung and Pancreatic Cancer Trials Are Stopped

April 30, 2010

James Watkins To Head AIDS Commission Following Mayberry’s Resignation

October 16, 1987

FDA Grants Accelerated Approval To Ferriprox for Iron Overload

October 28, 2011

FDA Moves to Regulate Lab-Developed Tests

August 1, 2014

In Brief: Contract Vs. Grants A Non-Issue, Upton Says In Farewell Appearance; Conte Eyes Chairmanship

January 18, 1980

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

October 29, 2010